Rimazolium
 | |
| Systematic (IUPAC) name | |
|---|---|
| 3-(Ethoxycarbonyl)-1,6-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-1-ium | |
| Clinical data | |
| Identifiers | |
|
35615-72-6 28610-84-6 (mesylate) | |
| N02BG02 | |
| PubChem | CID 71940 |
| ChemSpider | 64949 |
| Chemical data | |
| Formula |
C13H19N2O3 C14H22N2O7S (mesylate) |
|
251.30 g/mol 362.40 g/mol (mesylate) | |
|
SMILES
| |
| |
| Physical data | |
| Melting point | 165 to 166 °C (329 to 331 °F) (mesylate)[1] |
Rimazolium is a non-narcotic analgesic.[1][2] It is usually formulated as the mesylate salt rimazolium metilsufate.
References
- ↑ 1.0 1.1 Merck Index, 11th Edition, 8222
- ↑ Furst, S; Gyires, K; Knoll, J (1988). "Analgesic profile of rimazolium as compared to different classes of pain killers". Arzneimittel-Forschung 38 (4): 552–7. PMID 3261171.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||